U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07896577) titled 'Prophylactic PPI Use After EUS-GE Procedure' on Sept. 08.
Brief Summary: This study aims to compare the 6-month cumulative incidence of mucosal erosion or ulcer involving the anastomosis and LAMS flange in patients with and without 6-month prophylactic PPI treatment following EUS-GE, and to assess whether routine PPI use provides clear mucosal-protective effects
Study Start Date: Dec., 2026
Study Type: INTERVENTIONAL
Condition:
Malignant Gastric Outlet Obstruction
Intervention:
DRUG: Esomeprazole
Intravenous esomeprazole 40 mg (in 100 mL normal saline) on the day of procedure; after first oral intake, oral esomeprazole 20 mg ...